天目药业：8月26日召开董事会会议

Group 1 - The company Tianmu Pharmaceutical announced the convening of its 12th Board of Directors' 14th meeting on August 26, 2025, which was held through a combination of on-site and remote voting [1] - The meeting reviewed the proposal regarding the full text and summary of the company's 2025 semi-annual report [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into a human [1] - A dialogue with key participants discusses the timeline and challenges for clinical application of this groundbreaking procedure [1]